Table 1

Baseline characteristics, clinical data and self-rated health, internal consistency, and test of differences between intervention and control group (p value)

Intervention group (n=103)Control group (n=104)P value
Men, n (%)58 (56)51 (49)0.364*
Age, n1031040.500†
 Mean (SD)75.3 (10.1)74.3 (10.8)95% CI −1.89 to 3.86
 Median (Q1–Q3)77 (69–82)75 (68–83)
Having social support, n (%)75 (73)74 (71)0.358*
Income (SEK), n (%)0.169*
 <10 0004 (4)9 (9)
 10 000–20 00032 (31)43 (41)
 20 000–50 00034 (33)24 (23)
 >50 0008 (8)8 (8)
Education, n (%)0.553*
 < 9 years5 (5)6 (6)
 Primary school (9 years)21 (20)17 (16)
 Secondary school26 (25)39 (38)
 University28 (27)23 (22)
Country of birth, n (%)0.901*
 Sweden70 (68)71
 Nordic country other than Sweden6 (6)5 (5)
 Outside the Nordic countries5 (5)8 (8)
CCI, n94910.049
 Mean (SD)6.2 (2.0)5.7 (2.0)95% CI 0.003 to 1.15
 Median (Q1–Q3)6 (5–7)6 (5–7)
PHQ-9 (α=0.82), n73800.412*
 Mean (SD)8.5 (5.2)9.1 (6.5)
 Median (Q1–Q3)8 (5–12)8 (4–13)
EQ (α=0.76), n78860.744*
 Mobility
 Median (Q1–Q3)3 (2–4)3 (2–4)
 Self-care78860.392*
 Median (Q1–Q3)1 (1–2)1 (1–2)
 Usual activity77870.754*
 Median (Q1–Q3)3 (2–4)2 (2–4)
 Pain/discomfort78860.331*
 Median (Q1–Q3)3 (2–3)3 (2–3)
 Anxiety/depression77870.806*
 Median (Q1–Q3)2 (1–3)2 (1–3)
  • If the numbers in some columns do not add up to 104 or 103, it is because some of the participants did not respond. Significant p values are highlighted in bold.

  • 2 test for independence.

  • †Independent samples t-test.

  • CCI, age-adjusted Charlson Comorbidity Index; EQ EQ-5D-5L, European Quality of Life 5 Dimensions 5 Levels; PAM, Patient Activation Measure-13-S; PHQ-9, Patient Health Questionnaire; Q, quartile; SEK, Swedish krona; α, Cronbach’s alpha.